A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
Clinical trial NCT06882785 · RECRUITING
Trial details
- NCT number
- NCT06882785
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-10
- Primary completion
- 2028-09-23
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.